Clinical Trials Directory

Trials / Completed

CompletedNCT03934697

Imaginal Exposure II Study: In-Vivo

In-Vivo Treatment for Imaginal Exposure Therapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
43 (actual)
Sponsor
University of Louisville · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test if imaginal exposure therapy can decrease symptoms of eating disorders and anxiety.

Detailed description

An initial meeting consisting of a screening, questionnaires, and a brief psychoeducation on imaginal exposure therapy, followed by 8-10 sessions with a licensed psychologist (the PI) or a clinical psychology graduate student who is supervised and trained by the PI. In Session 1, patients will create a script with the therapist on an eating disorder fear. In sessions 2-10 the therapist and patient will then imagine this eating disorder related fear based on the script. Each session will be modified to focus on "hot spots" or the most feared aspect of the script. Sessions will be audiotaped and videotaped and participants will be asked to listen to the sessions nightly for homework. Sessions will be weekly or twice per week for 8-10 weeks after the initial screening session.

Conditions

Interventions

TypeNameDescription
BEHAVIORALimaginal exposure therapyAll participants will complete the same arm, which is ten sessions of imaginal exposure across a ten week time period. Each session is separated by 1 week.

Timeline

Start date
2017-05-01
Primary completion
2020-12-13
Completion
2022-10-01
First posted
2019-05-02
Last updated
2024-03-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03934697. Inclusion in this directory is not an endorsement.